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INTRODUCTION
The fibrotic lutng diseases are a heterogeneouis groupl) of chronic, usuially fatal disorders, characterized radiographically by a pattern of interstitial infiltration and physiologically by the loss of lutng voluime and a decrease in difftusing capacity. Histologically there is cellular infiltration of alveolar septa and an apparent increase in parenchymal collagen (1, 2) .
Althouigh some patients witlh ptulmonary fibrosis can be grouped according to etiology (e.g., occtupational, environmental, infectiouis, ttumor, or drtug) or by characteristic lung histology (e.g. eosinophilic grantuloma), many can be classified only as having "idiopathic pulmonary fibrosis" (IPF).' Althouigh the term 'IPF' implies that the etiology and pathogenesis of the disorder is unknown, tlhere are cluies which stuggest that inflammatory and/or immtune-mediated mechanisms are related to the contintued activity of the disease (3) .
In contrast to IPF, chronic hypersensitivity pneuimonitis (CHP) is a grouip of fibrotic lutng diseases in which the etiology is often known. With chronic inlhalation of certain organic antigens, stusceptible individtuals develop a granulomatous interstitial disease whicli often leads to significant parenchymal fibrosis (4) . Animal studies have stuggested that in hypersensitivity ' Abbreviations used in this paper: CHP, chronic hypersensitivity pneumonitis; C4, C6, hemolytic complements; E, erythrocyte; FEV,/FVC, forced expiratory volume (1 s)/ forced vital capacity; IPF, idiopathic pulmonary fibrosis; Pao2, mean resting arterial blood oxygen tension; PMN, polymorphonuclear leukocytes; SRBC, sheep red blood cells.
The Journal of Clinical Investigation Volume 59 January 1977 [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] pneumonitis, local immune reactions in the lungs, involving both humoral and cellular mechanisms, are intimately related to the pathogenesis and activity of the disease process (5, 6) .
Our understanding of these diseases, however, is restricted by limitations in the technologies available for their study. Lung tissue is not accessible for repeated studies and radiographical, physiological, and peripheral blood studies do not give a true assessment of the dynamic inflammatory and immune mechanisms operating in the local environment of the lung. The present study attempts to evaluate these mechanisms through an analysis of cellular and protein components in broncho-alveolar lavage fluid from a representative portion of the epithelial surface of the lower respiratory tract in patients with IPF The mean age of the 19 patients with IPF was 50.0+3.5 yr;2 12 were men and 7 were women. All patients with IPF met the following criteria: an interstitial pattern on chest film, reduced total lung capacity, reduced lung compliance, reduced single breath diffusing capacity, resting hypoxemia which worsened with exercise, and a normal forced expiratory volume (1 s)/forced vital capacity (FEV,/FVC). None had a significant environmental exposure, symptoms suggestive of hypersensitivity lung disease, left ventricular cardiac failure, or history of chronic pulmonary infections. 17 of the 19 patients with IPF had lung biopsies done within 2-11 mo before the broncho-alveolar lavage study. All biopsies showed septal fibrosis, septal cellular infiltration, and intra-alveolar cellularity. None Seven additional patients were referred to us as having IPF, but the episodic nature of the respiratory symptoms, serological studies, or histopathology of the lung biopsy suggested they had a form of hypersensitivity pneumonitis. All of the patients had a history of chronic intermittent respiratory and systemic symptoms related to their home or work environment. Four of the patients had acute episodes characterized by chills and fever accompanied by cough and dyspnea. The other three had a more insidious onset of cough and progressive dyspnea with no chills or fever. Four patients noted relief of symptoms when removed from their home or work environment and an exacerbation of symptoms with re-exposure to the apparent source of antigens. In four patients, the chest X-ray abnormalities have tended to persist even with removal from the apparent antigenic source. The mean physiologic data for these seven patients were: vital capacity, 82 Table I. Control patients. 32 patients (20 men, 12 women) with undiagnosed lesions limited to the right upper lung underwent broncho-alveolar lavage in the lingula or left lower lobe as part of the diagnostic bronchoscopy (7) . 21 smoked cigarettes and 11 did not. None had evidence by physical examination or chest X ray of disease in the left lung and none were receiving drugs. The controls were age-matched for the IPF patients (nonsmokers 52.0±3.0 yr; smokers 48.0±2.4 yr).
Bronchoscopy and broncho-alveolar lavage. Informed consent was obtained from all patients. Patients were premedicated intramuscularly with atropine (0.6 mg) and diazepam (10 mg); topical lidocaine spray (2%) was used to obtain local anesthesia in the respiratory tract. 'Bronchoscopies were performed transnasally with a flexible fiberoptic instrument (model BFT 5B-2, Olympus Corporation of America, New Hyde Park, N. Y.). Bronchoscopy was done in the morning, approximately 3 h after prednisone was given to patients receiving this medication. The procedure was done with constant cardiac monitoring and with an intravenous infusion in place. If the resting arterial P02 on room air was below 70 mm Hg, the bronchoscopy was done with supplemental oxygen given by nasal prongs or face mask (with side port for the instrument).
After routine examination of the major airways, the bronchoscope was positioned in a segment of the lingula (B4 or 5).
A total of 100 ml of sterile 0.9%o saline (Abbott Laboratories, North Chicago, Ill.) was infused (30 ml twice and then 40 ml) and aspirated by suction after each infusion. The lavage fluid was immediately strained through a single layer of gauze to remove gross mucus and then centrifuged (500 g, 5 min) to separate cellular and protein components. The supernate was carefully decanted from the cell pellet for subsequent protein analysis.
Cellular analysis. Cl., 6. C:. * Broncho-alveolar lavage was concentrated to a 1.0-ml volume. 4 Includes nonsmokers and smokers. § Mean±SEM, range for the group observed given in parentheses. The difference in total cells recovered in IPF (no therapy) and control (nonsmokers) was significantly different (Student's t test, P < 0.05). ¶ The concentration of protein and albumin in lavage fluid of patients with CHP was significantly greater than that in all other groups (P < 0.05 all cases). ** 10 lavages in seven patients; repeat lavages after general clinical improvement, generally showed a decrease in total protein concentration (J. G. 23.0-8.2 mg/ml; R. B. 26.0-8.9 mg/ml; W. C. 17.0-7.0 mg/ml). FN, Coulter Electronics, Hialeah, Fla.), viability (8) and differential counts. The latter were made from cytocentrifuge smears stained with Wright-Giemsa.
For patients with CHP, the relative proportions of bone marrow-derived (B) and thymus-derived (T) lymphocytes were determined in lavage and peripheral blood. Lymphocytes were separated from the respiratory cell pellet or from heparinized blood with a two-step procedure (9) . First, mononuclear cells were banded by density gradient centrifugation with Hypaque-Ficoll (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) (10) and subsequently washed three times in Eagle's minimum essential medium (Grand Island Biological Co., Grand Island, N. Y.). Secondly, columns of Sephadex G-10 (Pharmacia Fine Chemicals, Inc.) were used to deplete the cell preparations of monocytes or alveolar macrophages (11, 12) . For respiratory cells, a column of 10 ml Sephadex gel was equilibrated with Eagle's minimum essential medium containing 10% fetal calf serum, 107 cells were washed into the column and the nonadherent cells were eluted with Eagle's minimum essential medium at room temperature. For blood cells the column was made with 30 ml of Sephadex and 108 cells were used. This column method consistently yielded a 95-98% pure population of lymphocytes with viability of at least 95%. The net recovery of total lymphocytes from the original cell pellet was 85.0±4.0%o.
Comparison of the original cell pellet and the postcolumn purified lymphocytes showed no change in the relative proportion of T and B lymphocytes (12) . The percentage of T lymphocytes were defined as those forming erythrocyte (E) rosettes with sheep red blood cells (SRBC) (13) . The percentage of B lymphocytes was defined as those forming rosettes with SRBC (E)-rabbit IgM-anti-SRBC antibody (A)-mouse serum complement (C) complexes (EAC rosettes) (14, 15) . Details of these reagents and procedures have been described elsewhere (16) .
Protein analysis. The supernate from the initial centrifugation was concentrated at 40C to a final volume of 1.0 ml with a combination of positive pressure ultrafiltration (Diaflo, UM-10 membrane, Amicon Corp., Scientific Sys. Div., Lexington, Mass.) and negative pressure dialysis. Quantitative measurements in this concentrated lavage included: total protein by the Lowry method (17); albumin and immunoglobins G and M by radial immunodiffusion in agar (Behring Diagnostics, American Hoechst, Somerville, N. J.); IgE with a radioimmunoabsorbent method (Pharmacia Laboratories Inc.); and hemolytic complement (C4 and C6 titers) (18, 19 Sinice prior studclies lhavxe demonstrated inl normiial subjects that cigarette smiioking can significantly influience thle recovery of respiratory cells (7, (21) (22) (23) , resuilts fromii patients with IPF are also segregatedl as to smloking statuis (Table II) . The percentage of lavage flutid recovered fromi patients with IPF on no therapy tended to be less thaln from other grouips, particiularly the nonsmoking controls (P = 0.08) ( Table IL) probably secondary to the relative increase in PMNs in these patients. The percentage of eosinophils (Fig. IC) in the IPF cell differentials was significantly higher (P < 0.001) than for control subjects in whom eosinophils -were not detected. Eosinophils persisted in IPF despite anti-inflammatory therapy. The number of eosinophils in the peripheral blood of these patients was not elevated except for mildly increased absolute circulating eosinophil counts in 3 of the 19 IPF patients (718 +46 eosinophils/mm3 for the 3 patients).
The percentage of lymphocytes in IPF lavage fluid (Fig. ID) (Table II) .
Serum IgG to albumin ratios were similar in all patients; the individual ratios were always less thlan 0.65 (Fig. 2) (Fig. 2) . In general, patients on treatment for IPF had lower ratios of lavage IgE/albumin than smoker controls (P < 0.025) despite considerable variation in the control values. 50% of the untreated IPF patients also had lower lavage IgE/albumin valtues than controls, but the mean for this group was not significantly lower than controls (P > 0.1). Unfortunately, data were not available for nonsmoker controls, btut restults obtained in nonsmoking voltunteers demonstrate lavage IgE/albumin values comparable to those fouind in the smoker controls (7) . Sertum levels of IgE/albumin were similar in all groups. Lavage IgE/albumin for some IPF patients tended to be higher than that in seruim; for controls the lavage values were significantly higher than serum values (P < 0.001) (Fig. 2) With double-diffusion immunoprecipitation analysis of lavage fluid, IgM was detected in only 15% of specimens from IPF patients (sensitivity of the IgM assay was 0.1 mg/ml). Likewise, this immtunoglobtulin was found in approximately 5% of control specimens (7) . Serum IgM values were within the normal range for our laboratory (0.9-1.7 mg/ml) for IPF patients on no therapy (1.5+0.3 mg/ml) and for those on treatment (1.7+0.3 mg/ml). Serum values for control nonsmokers (1.8+0.2 mg/ml) and smokers (1.5+0.3 mg/ml) were comparable.
C4 hemolytic complement titers in lavage, expressed as a ratio to albumin, were the same for the IPF grouips and for smoker controls (Fig. 3) . However, mean ratios in lavage fluid were significantly lower (P < 0.01) than corresponding serum ratios for the (Fig. 4) . (A higlher percentage was noted for patient R. K. and for the second analysis in R. B. and W. C.; both of these latter patients had an episode of bronchitis 3-4 wk before the second lavage study.) Eosinophils represented 0.5-2% of all respiratory cells of patients with CHP wlhile approximately 29% of the lavage cells were alveolar macrophages with distinctive foamy macroplhages constituting about 10% of the macrophage popuilation.
In striking contrast to patients with IPF and to controls, lymphocytes accouinted for approximately 62% of the lavage cells in CHP. Whien lavage lymphocytes were characterized by sheep erythrocyte (T cells) and complement (B cells) rosette techlniquies (Fig. 4) (Table II) . Part of the excess broncho-alveolar protein inl CHP was IgG. With the exception of the second analysis of R. B., the ratios of lavage IgG/albumin were .1.1 in all cases of CHP. These ratios were higlher than those fotund in 75% of the IPF patients and higher than any controls (Fig. 5 vs. Fig. 2 ). In contrast, the corresponding seruim ratios in CHP (mean 0.42+0.03) were similar to IPF and controls. IgG-rich fractions recovered from stucrose gradient fractionation of lavage 172 Reynolds, Fulmer, Kazmierowski, Roberts, Frank, and Crystal IgM vas measurable in all lavage specimens in CHP; its mere detection made it unusual in comparison with IPF (15% had lavage IgM) or controls (5% had lavage IgM). The IgM/albumin levels in lavage vs. serum (Fig. 5) indicated a proportionally greater amount in the bronchoalveolar fluid than in serum. No precipitating antibodies were detected in lavage or serum IgM fractions recovered from sucrose gradients.
IgE/albumin levels in CHP lavage were higher than those found in serum. The lavage and serum ratios, however, were normal compared to the smoker controls (Fig. 5 vs. Fig. 2) . Total IgA/albumin in CHP lavage was elevated compared with serum but was similar to controls. As found in IPF and controls, C4/albumin and C6/albuimin levels were lower in CHP lavage fluid as compared with serum.
DISCUSSION
Limited lavage of the lower respiratory tract is a simple extension of routine fiber-optic bronchoscopy. While routine measurements, such as chest films and pulmonary function studies, monitor general lung ftunction, analysis of broncho-alveolar lavage fluid is a direct attempt to evaluate specific mechanisms which may contribute to the continued activity of lung disease. Quantitation (3, (27) (28) (29) . Tlhtus disease mechanisms in IPF and CHP are probably not associttedl witlh combined type I aiud III immuiiitine reaction;s fiound in a disorder stuchl as alllergic bronchopulmiioinatry asp)ergillosis (3 There isi no direct evidence in these sttudies tlat either IPF of' CHP are associated with local complement-miiedi ated reactionis. Althouigh C4/albu min levels in the broncho-alveolar fluiid tended to be lower thalnl serumiii (Figs. 3, 5) , there was n1o difference between IPF, CHP, or conitrols. The lower valtues of complemiient activity in all lavage analyses may be more apparent tlhain biologically significant. Althouighi complemiienit titers were promptly assayed, its activity is known to be labile aind undoubtedly some activity is lost in the lutng washouit and concenitratinig piroceduires. The elevated levels of seruim C6 in IPF aind CHP miay be duie to C6 acting as acn atcutte phalse reactaint in these pati ents.
While the eosinophils, IgG, IgA, IgE, C4, aind C6 levels in the lavage fluiid of IPF an CHP are quiite similar, ancalysis of other celluilar and protein contents of the bronclho-alveolar fluiid in CHP provides a striking contrast to thsat in IPF aind controls. Lavage fluiid of these patients contained alveolar macrophages with foamiiy cytoplassm which are considered to be characteristic of the histology fouind in the hypersensitivity ltng disorders (4) . Suich cells were not noted in IPF or controls. In 10 lavage analyses from 7 patients witlh CHP, the average percentage of broncho-alveolar lymplhocytes was 62% comnpared to abouit 10% in IPF (treated and uintreated), 8% in smoker controls ancl 18% in nonsmoker controls. Even thouigh all patients with CHP had elevated broncho-alveolar IgG and IgM, and two hald IgG precipitating antibodies in the lavage fluiid against a specific fu-ngal antigen, the exaggerated broncho-alveolar lymiiplhocyte response in CHP is not one of B lym)phocytes, as miglht be expected, but rather one of T lymphocytes. This finding suiggests, as in experimiienital aniimnal models of hypersensitivity pnetimonitis (5, 6), thlat cell-mediated mechanismns miay also be imsportaint in CHP. Tlhuis, in hulmtlclan hypersenisitivity disease, there is L)reliminary evidence of' localized humnioral aind celluilar immuiwtnity in the pathogenesis of'the dlisordler. The consequiences of'this T-cell acctcumutilation in CHP are uniiknowni, althouiglh it is possible that activation of these cells to liberate local mediators may provide a stimulus for granuloma formation, eosiinophil accu muItiati oi ancl/or cell injtury.
Based on the highi ratio of T/B lymplhocytes foutnd in CHP lavage fluid compared to blood (Fig. 4) , T cells appeared to be seqtiestered in affected pulmonary tisstue. This find(iniig was even more striking when comlpared to the recent stuidies of' Daniele et al. (30) wlho noted that in normal hui1mains, broncho-alveolar T/B ratios were the saml1e as in 1)lood. These lymiiplhocvte restilts together witlh the immutnoglobuilin data in both IPF aind CHP stuggest that the luing cani fuinction partially independent of systemic htumoral-annd cellmediated immuniiie systemiis.
Ltung biopsies were available fromii 17 is uisuially done only once to establish a diagnosis, broncho-alveolar lavage does permit periodic assessment of' the disease process with little risk and discomfort to the patient. Thtus, analysis of lavage fluiid from patients with fibrotic lutng disease adds anoth-er dimension to evaltuationi of these disorders. Lavage fluiid represents the epithelial milieui of the luing parenchyma and therefore gives fturther insight into local phenomena causing the lutng disease. It may prove uiseftul in following the effect of therapy Oilthese disorders. Most importantly, the differences between the cellular analyses in CHP compared to IPF and controls indicate that broncho-alveolar lavage cotuld be uiseftul diagnostically in categorizing patients with ptulmonary fibrosis exen when specific organic antigens cannot be readily identified.
